Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases.

Mauro FaticaBenedetta MonosiPaola ConigliaroArianna D'AntonioSara EssofiElisa CuccagnaAlberto BergaminiLivia BianconeGiovanni MonteleonePaola TriggianeseEmma CalabreseMaria Sole Chimenti

Published in: RMD open (2024)

bDMARDs treatment had an impact in reducing SpA development and clinical associated risk factors to transition from IBD to IBD-SpA emerged.

Keyphrases

rheumatoid arthritis
ulcerative colitis
stem cells
combination therapy
mesenchymal stem cells
bone marrow